169 related articles for article (PubMed ID: 33610543)
21. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
22. Frequency of surgical resection after starting neoadjuvant chemoradiotherapy in patients with esophageal cancer: A population-based cohort study.
Borggreve AS; van Rossum PSN; Mook S; Haj Mohammad N; van Hillegersberg R; Ruurda JP
Eur J Surg Oncol; 2019 Oct; 45(10):1919-1925. PubMed ID: 30975447
[TBL] [Abstract][Full Text] [Related]
23. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses.
Shi Z; Zhu X; Ke S; Qiu H; Cai G; Zhangcai Y; Chen Y
Radiother Oncol; 2021 Nov; 164():236-244. PubMed ID: 34627936
[TBL] [Abstract][Full Text] [Related]
24. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.
Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM
Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634
[TBL] [Abstract][Full Text] [Related]
25. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.
Liu S; Wen J; Yang H; Li Q; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Zhao L; Liu H; Hu Y; Liu M; Fu J; Xi M
Eur J Cancer; 2020 Oct; 138():113-121. PubMed ID: 32877795
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.
Lin HN; Chen LQ; Shang QX; Yuan Y; Yang YS
Int J Surg; 2020 Aug; 80():184-191. PubMed ID: 32659390
[TBL] [Abstract][Full Text] [Related]
27. A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases.
Dijksterhuis WPM; Kroese TE; Verhoeven RHA; van Rossum PSN; Mook S; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Ruurda JP; van Oijen MGH; van Hillegersberg R; van Laarhoven HWM
Eur J Surg Oncol; 2022 Sep; 48(9):1964-1971. PubMed ID: 35314096
[TBL] [Abstract][Full Text] [Related]
28. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
30. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
Hsu PK; Chien LI; Wang LC; Chou TY;
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
[TBL] [Abstract][Full Text] [Related]
32. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
33. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
34. (Neo)adjuvant Chemoradiotherapy is Beneficial to the Long-term Survival of Locally Advanced Esophageal Squamous Cell Carcinoma: A Network Meta-analysis.
Jin Z; Chen D; Chen M; Wang C; Zhang B; Zhang J; Zhu C; Shen J
World J Surg; 2022 Jan; 46(1):136-146. PubMed ID: 34482411
[TBL] [Abstract][Full Text] [Related]
35. Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery.
Li X; Luan S; Yang Y; Zhou J; Shang Q; Fang P; Xiao X; Zhang H; Yuan Y
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954385
[TBL] [Abstract][Full Text] [Related]
36. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
37. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.
Ikawa T; Ishihara R; Konishi K; Morimoto M; Hirata T; Kanayama N; Yamamoto S; Matsuura N; Wada K; Hayashi K; Ogawa K; Teshima T
Cancer Med; 2019 Aug; 8(10):4547-4554. PubMed ID: 31222974
[TBL] [Abstract][Full Text] [Related]
38. Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis.
Hsu HY; Chao YK; Hsieh CH; Wen YW; Chang HK; Tseng CK; Liu YH
Ann Thorac Surg; 2016 Nov; 102(5):1687-1693. PubMed ID: 27457831
[TBL] [Abstract][Full Text] [Related]
39. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
40. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
